Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Virginia Commonwealth University
- Study ID
- NCT05334732
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SIS TALK Back Intervention — BEHAVIORALThe participants in this arm will be seen by a trained survivor coach and receive culturally tailored intervention materials.
Study Details
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Key Dates
- Start date
- Mar 1, 2021
- Status verified
- Apr 2026
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Sisters Informing Sisters SessionsThe intervention is peer-based and in concert with our theoretical model, builds upon positive role-modeling of the survivor coach to the patient, addresses behavioral expectations/capacities, and uses Motivational Interviewing (MI) techniques. The intervention includes a culturally relevant coach's manual and a patient workbook that will be used to facilitate the coaching sessions.
- No Intervention: Enhanced Usual CareWomen in the EUC arm will receive usual care that includes standardized information in the public domain (NCI treatment information booklet). This booklet was chosen to provide women with national-level recommendations regarding treatment recommendations.
Primary Outcome Measure
Assessing Study Adherence Behaviors- Initiation [ Time Frame: 36 Months ]
Central Contacts
- Vanessa B Sheppard, Ph.D804-682-2700
- Yvonne D Cummings, BS804-828-0643
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medstar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | Hurtado de Mendoza Lucile Adams-Campbell (PRINCIPAL_INVESTIGATOR) |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | - |
| Massey Cancer Center | Richmond | Virginia | 23298 |
Find similar trials in Washington D.C., DC
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska